GLP-1 Receptor Agonists in Glaucoma Care - Top-Institutions - MDSpire

GLP-1 Receptor Agonists in Glaucoma Care

Glaucoma exists at the intersection of vascular dysregulation, metabolic stress, and neurodegeneration.

  • By

  • Mike Cymbor, OD, FAAO

  • March 2, 2026

  • 3 min

Share

Top Institutions in Optometry

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Neuro-ophthalmology

  • #2

    Massachusetts Eye and Ear Infirmary, Harvard Medical School
    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Neurodegeneration

  • #3

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Neuro-ophthalmology

  • #4

    Mayo Clinic Department of Ophthalmology
    Mayo Clinic Department of Ophthalmology

    Rochester, MN

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Neurodegenerative Disease

  • #5

    University of California, San Francisco (UCSF) Department of Ophthalmology
    University of California, San Francisco (UCSF) Department of Ophthalmology

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Neurodegeneration

Original Source(s)

GLP-1 Receptor Agonists in Glaucoma Care

  • by Mike Cymbor, OD, FAAO

  • March 2, 2026

Related Content

The Art of Ophthalmology 2026

Showcasing artwork and images from across the spectrum of ophthalmology

Rerouting Eye Care: How AI and Telemedicine Are Reshaping Ophthalmology Patient Journeys in the United Kingdom and Germany

AACE 2026: Will AI replace endocrinologists?

The same technology drawing patients away from clinic may also improve the patient-physician relationship.